ESAIY
Price
$8.68
Change
+$0.23 (+2.72%)
Updated
Sep 5 closing price
Capitalization
9.77B
HLUBF
Price
$4.97
Change
+$0.38 (+8.28%)
Updated
Aug 22 closing price
Capitalization
6.17B
Interact to see
Advertisement

ESAIY vs HLUBF

Header iconESAIY vs HLUBF Comparison
Open Charts ESAIY vs HLUBFBanner chart's image
Eisai
Price$8.68
Change+$0.23 (+2.72%)
Volume$39.46K
Capitalization9.77B
H. Lundbeck A/S
Price$4.97
Change+$0.38 (+8.28%)
Volume$200
Capitalization6.17B
ESAIY vs HLUBF Comparison Chart in %
Loading...
ESAIY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLUBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESAIY vs. HLUBF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESAIY is a StrongBuy and HLUBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (ESAIY: $8.68 vs. HLUBF: $4.97)
Brand notoriety: ESAIY and HLUBF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ESAIY: 40% vs. HLUBF: 28%
Market capitalization -- ESAIY: $9.77B vs. HLUBF: $6.17B
ESAIY [@Pharmaceuticals: Generic] is valued at $9.77B. HLUBF’s [@Pharmaceuticals: Generic] market capitalization is $6.17B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESAIY’s FA Score shows that 2 FA rating(s) are green whileHLUBF’s FA Score has 1 green FA rating(s).

  • ESAIY’s FA Score: 2 green, 3 red.
  • HLUBF’s FA Score: 1 green, 4 red.
According to our system of comparison, ESAIY is a better buy in the long-term than HLUBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESAIY’s TA Score shows that 5 TA indicator(s) are bullish while HLUBF’s TA Score has 3 bullish TA indicator(s).

  • ESAIY’s TA Score: 5 bullish, 4 bearish.
  • HLUBF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both ESAIY and HLUBF are a good buy in the short-term.

Price Growth

ESAIY (@Pharmaceuticals: Generic) experienced а +13.55% price change this week, while HLUBF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESAIY($9.77B) has a higher market cap than HLUBF($6.18B). ESAIY has higher P/E ratio than HLUBF: ESAIY (31.36) vs HLUBF (9.04). ESAIY YTD gains are higher at: 28.709 vs. HLUBF (12.190). ESAIY has higher annual earnings (EBITDA): 101B vs. HLUBF (4.82B). ESAIY has more cash in the bank: 269B vs. HLUBF (2.65B). HLUBF has less debt than ESAIY: HLUBF (13.6B) vs ESAIY (183B). ESAIY has higher revenues than HLUBF: ESAIY (753B) vs HLUBF (23.5B).
ESAIYHLUBFESAIY / HLUBF
Capitalization9.77B6.18B158%
EBITDA101B4.82B2,096%
Gain YTD28.70912.190236%
P/E Ratio31.369.04347%
Revenue753B23.5B3,204%
Total Cash269B2.65B10,162%
Total Debt183B13.6B1,346%
TECHNICAL ANALYSIS
Technical Analysis
ESAIYHLUBF
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
28%
Momentum
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 3 days ago
9%
MACD
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 3 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 3 days ago
28%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
36%
Advances
ODDS (%)
Bullish Trend 3 days ago
62%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
73%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
50%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
32%
View a ticker or compare two or three
Interact to see
Advertisement
ESAIY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLUBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LABU82.545.03
+6.49%
Direxion Daily S&P Biotech Bull 3X ETF
KOLD35.641.17
+3.39%
ProShares UltraShort Bloomberg Natrl Gas
RINC22.630.39
+1.76%
AXS Real Estate Income ETF
USIG52.040.26
+0.50%
iShares Broad USD Invm Grd Corp Bd ETF
NFLU61.52-1.68
-2.66%
T-REX 2X Long NFLX Daily Target ETF

ESAIY and

Correlation & Price change

A.I.dvisor tells us that ESAIY and ESALF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESAIY and ESALF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESAIY
1D Price
Change %
ESAIY100%
+2.66%
ESALF - ESAIY
30%
Poorly correlated
+0.06%
GEDSF - ESAIY
28%
Poorly correlated
N/A
SDZNY - ESAIY
8%
Poorly correlated
+0.74%
PLNH - ESAIY
7%
Poorly correlated
+10.91%
CNADF - ESAIY
5%
Poorly correlated
N/A
More

HLUBF and

Correlation & Price change

A.I.dvisor tells us that HLUBF and HLBBF have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLUBF and HLBBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLUBF
1D Price
Change %
HLUBF100%
N/A
HLBBF - HLUBF
19%
Poorly correlated
N/A
HLNCF - HLUBF
7%
Poorly correlated
-0.61%
ESAIY - HLUBF
5%
Poorly correlated
+2.66%
EAPIF - HLUBF
0%
Poorly correlated
N/A
BGLAF - HLUBF
-0%
Poorly correlated
N/A
More